Terms: = Leukemia AND ZFHX3, ATBT, 463, ENSG00000140836, Q15911 AND Treatment
38 results:
1. All-Cause and Cause-Specific Mortality Among Low-Risk Differentiated Thyroid Cancer Survivors in the United States.
Tran TV; Schonfeld SJ; Pasqual E; Haymart MR; Morton LM; Kitahara CM
Thyroid; 2024 Feb; 34(2):215-224. PubMed ID: 38149602
[No Abstract] [Full Text] [Related]
2. Covalent targeting the LAS1-NOL9 axis for selective treatment in NPM1 mutant acute myeloid leukemia.
Han Y; Hu A; Qu Y; Xu Q; Wang H; Feng Y; Hu Y; He L; Wu H; Wang X
Pharmacol Res; 2023 Mar; 189():106700. PubMed ID: 36796466
[TBL] [Abstract] [Full Text] [Related]
3. Letermovir for Prophylaxis and Pre-emptive Therapy of Cytomegalovirus Infection in Paediatric Allogeneic Haematopoietic Cell Transplant Patients.
Körholz KF; Füller MA; Hennies M; Holterhus M; Hagedorn S; Ahlmann M; Thorer H; Burkhardt B; Groll AH
Paediatr Drugs; 2023 Mar; 25(2):225-232. PubMed ID: 36572834
[TBL] [Abstract] [Full Text] [Related]
4. TRough versus AUC Monitoring of cyclosporine: A randomized comparison of adverse drug reactions in adult allogeneic stem cell recipients (TRAM study).
Kuijvenhoven MA; Wilhelm AJ; Meijer E; Janssen JJWM; Swart EL
Eur J Haematol; 2021 Sep; 107(3):364-369. PubMed ID: 34114691
[TBL] [Abstract] [Full Text] [Related]
5. Fatigue in newly diagnosed acute myeloid leukaemia: general population comparison and predictive factors.
Oswald LB; Venditti A; Cella D; Cottone F; Candoni A; Melillo L; Cairoli R; Storti G; Salutari P; Luppi M; Albano F; Martelli MP; Cuneo A; Tafuri A; Trisolini SM; Tieghi A; Fazi P; Vignetti M; Efficace F
BMJ Support Palliat Care; 2023 Dec; 13(e2):e344-e351. PubMed ID: 33941573
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic factors for neutrophil engraftment after haploidentical cell transplantation with PT-Cy in patients with acute myeloid leukemia in complete remission, on behalf of the ALWP-EBMT.
Ruggeri A; Labopin M; Angelucci E; Blaise D; Ciceri F; Koc Y; Chiusolo P; Diez-Martin JL; Gülbas Z; Castagna L; Bruno B; Arat M; Martino M; Nagler A; Mohty M
Bone Marrow Transplant; 2021 Aug; 56(8):1842-1849. PubMed ID: 33674790
[TBL] [Abstract] [Full Text] [Related]
7. Menin‑MLL inhibitors induce ferroptosis and enhance the anti‑proliferative activity of auranofin in several types of cancer cells.
Kato I; Kasukabe T; Kumakura S
Int J Oncol; 2020 Oct; 57(4):1057-1071. PubMed ID: 32945449
[TBL] [Abstract] [Full Text] [Related]
8. Integrative genomic analyses reveal mechanisms of glucocorticoid resistance in acute lymphoblastic leukemia.
Autry RJ; Paugh SW; Carter R; Shi L; Liu J; Ferguson DC; Lau CE; Bonten EJ; Yang W; McCorkle JR; Beard JA; Panetta JC; Diedrich JD; Crews KR; Pei D; Coke CJ; Natarajan S; Khatamian A; Karol SE; Lopez-Lopez E; Diouf B; Smith C; Gocho Y; Hagiwara K; Roberts KG; Pounds S; Kornblau SM; Stock W; Paietta EM; Litzow MR; Inaba H; Mullighan CG; Jeha S; Pui CH; Cheng C; Savic D; Yu J; Gawad C; Relling MV; Yang JJ; Evans WE
Nat Cancer; 2020 Mar; 1(3):329-344. PubMed ID: 32885175
[TBL] [Abstract] [Full Text] [Related]
9. The impact of donor type on the outcome of pediatric patients with very high risk acute lymphoblastic leukemia. A study of the ALL SCT 2003 BFM-SG and 2007-BFM-International SG.
Dalle JH; Balduzzi A; Bader P; Pieczonka A; Yaniv I; Lankester A; Bierings M; Yesilipek A; Sedlacek P; Ifversen M; Svec P; Toporski J; Gungor T; Wachowiak J; Glogova E; Poetschger U; Peters C
Bone Marrow Transplant; 2021 Jan; 56(1):257-266. PubMed ID: 32753706
[TBL] [Abstract] [Full Text] [Related]
10. Comparative Safety and Health Care Expenditures Among Patients With Chronic Myeloid leukemia Initiating First-Line Imatinib, Dasatinib, or Nilotinib.
Cole AL; Wood WA; Muluneh B; Lund JL; Elston Lafata J; Dusetzina SB
JCO Oncol Pract; 2020 May; 16(5):e443-e455. PubMed ID: 32196424
[TBL] [Abstract] [Full Text] [Related]
11. Effect of laminar air flow and building construction on aspergillosis in acute leukemia patients: a retrospective cohort study.
Iwasaki M; Kanda J; Hishizawa M; Kitano T; Kondo T; Yamashita K; Takaori-Kondo A
BMC Infect Dis; 2019 Jan; 19(1):38. PubMed ID: 30626352
[TBL] [Abstract] [Full Text] [Related]
12. [Diagnostic and therapeutic values of interphase fluorescence in situ hybridization in B-cell lymphomas: a clinicopathologic analysis of 604 cases].
Chen M; Yang JL; Zhao S; Liu WP; Li GD; Ye YX; Yan JQ; Zhang WY
Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):920-925. PubMed ID: 30522172
[No Abstract] [Full Text] [Related]
13. Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort.
Gibson TM; Mostoufi-Moab S; Stratton KL; Leisenring WM; Barnea D; Chow EJ; Donaldson SS; Howell RM; Hudson MM; Mahajan A; Nathan PC; Ness KK; Sklar CA; Tonorezos ES; Weldon CB; Wells EM; Yasui Y; Armstrong GT; Robison LL; Oeffinger KC
Lancet Oncol; 2018 Dec; 19(12):1590-1601. PubMed ID: 30416076
[TBL] [Abstract] [Full Text] [Related]
14. High-Dose Vincristine Sulfate Liposome Injection, for Advanced, Relapsed, or Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic leukemia in an Adolescent and Young Adult Subgroup of a Phase 2 Clinical Trial.
Schiller GJ; Damon LE; Coutre SE; Hsu P; Bhat G; Douer D
J Adolesc Young Adult Oncol; 2018 Oct; 7(5):546-552. PubMed ID: 30239252
[TBL] [Abstract] [Full Text] [Related]
15. Incidence, time of occurrence and response to heart failure therapy in patients with anthracycline cardiotoxicity.
Khan AA; Ashraf A; Singh R; Rahim A; Rostom W; Hussain M; Renner I; Collins NJ
Intern Med J; 2017 Jan; 47(1):104-109. PubMed ID: 27800661
[TBL] [Abstract] [Full Text] [Related]
16. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
Place AE; Stevenson KE; Vrooman LM; Harris MH; Hunt SK; O'Brien JE; Supko JG; Asselin BL; Athale UH; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JJ; Lipshultz SE; Kutok JL; Blonquist TM; Neuberg DS; Sallan SE; Silverman LB
Lancet Oncol; 2015 Dec; 16(16):1677-90. PubMed ID: 26549586
[TBL] [Abstract] [Full Text] [Related]
17. [treatment of Ph-adult acute lymphoblastic leukemia patients with Tongji-96 regimen].
Ding Y; Li P; Zhang W; Wu H; Chen Y; Xiu B; Lu H; Li B; Fu J; Bo L; Liang A
Zhonghua Xue Ye Xue Za Zhi; 2015 Apr; 36(4):272-6. PubMed ID: 25916284
[TBL] [Abstract] [Full Text] [Related]
18. Pharmacologic inhibition of the Menin-MLL interaction blocks progression of MLL leukemia in vivo.
Borkin D; He S; Miao H; Kempinska K; Pollock J; Chase J; Purohit T; Malik B; Zhao T; Wang J; Wen B; Zong H; Jones M; Danet-Desnoyers G; Guzman ML; Talpaz M; Bixby DL; Sun D; Hess JL; Muntean AG; Maillard I; Cierpicki T; Grembecka J
Cancer Cell; 2015 Apr; 27(4):589-602. PubMed ID: 25817203
[TBL] [Abstract] [Full Text] [Related]
19. Associations of novel genetic variations in the folate-related and ARID5B genes with the pharmacokinetics and toxicity of high-dose methotrexate in paediatric acute lymphoblastic leukaemia.
Csordas K; Lautner-Csorba O; Semsei AF; Harnos A; Hegyi M; Erdelyi DJ; Eipel OT; Szalai C; Kovacs GT
Br J Haematol; 2014 Aug; 166(3):410-20. PubMed ID: 24712521
[TBL] [Abstract] [Full Text] [Related]
20. Host genetic variants of ABCB1 and IL15 influence treatment outcome in paediatric acute lymphoblastic leukaemia.
Lu Y; Kham SK; Ariffin H; Oei AM; Lin HP; Tan AM; Quah TC; Yeoh AE
Br J Cancer; 2014 Mar; 110(6):1673-80. PubMed ID: 24434428
[TBL] [Abstract] [Full Text] [Related]
[Next]